scispace - formally typeset
P

Paul R. Sleath

Researcher at Corixa Corporation

Publications -  22
Citations -  2114

Paul R. Sleath is an academic researcher from Corixa Corporation. The author has contributed to research in topics: Antigen & Epitope. The author has an hindex of 11, co-authored 22 publications receiving 2004 citations. Previous affiliations of Paul R. Sleath include GlaxoSmithKline.

Papers
More filters
Journal ArticleDOI

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

TL;DR: The first glimpse of the total human T cell response to a complex infectious agent is provided and insight into the rules governing immunodominance and cross-reactivity in complex viral infections of humans is provided.
Journal Article

Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine.

TL;DR: It is validates that a similar peptide-based vaccine formulation is effective for inducing T-cell immunity to HER-2/neu protein in humans with breast and ovarian cancer.
Journal ArticleDOI

Diversity of the CD8+ T-Cell Response to Herpes Simplex Virus Type 2 Proteins among Persons with Genital Herpes

TL;DR: The magnitude and breadth of the response in the infected population were greater than previously appreciated and whether this variability in the CD8+ T-cell response within individuals is associated with the frequency of viral reactivation warrants further study.
Journal ArticleDOI

A Multi-Epitope Synthetic Peptide and Recombinant Protein for the Detection of Antibodies to Trypanosoma cruzi in Radioimmunoprecipitation-Confirmed and Consensus-Positive Sera

TL;DR: These studies show that peptides and recombinants containing multiple repeat epitopes are powerful tools for developing assays for T. cruzi antibody detection and have direct application in blood screening.
Journal ArticleDOI

Identification and synthesis of a major conserved antigenic epitope of Trypanosoma cruzi.

TL;DR: A gene sequence encoding an immunodominant protein with a repetitive epitope from the protozoan Trypanosoma cruzi, the causative agent of Chagas disease, was cloned and expressed and present within a high-molecular-weight trypomastigote antigen that appears specific to and conserved among T. cruzi isolates.